Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Type of study
Language
Year range
1.
Tunisie Medicale [La]. 2008; 86 (1): 32-37
in French | IMEMR | ID: emr-90535

ABSTRACT

Serum total IgE measurement is one of the first allergic inflammation marker test. It has been currently used for the diagnosis of allergy. However, when it has been widely used in clinical practice, we discover its limit in the diagnosis of allergic disease. We carried a retrospective study about 1111 consecutive patients, seen in the Allergology Unit of the Home Ministry Hospital with suspicion of atopic disease. The aim of our study is to evaluate the contribution of serum total IgE measurement in the diagnosis of respiratory allergic diseases. Our population was divided into three groups. Group A: 771 allergic symptomatic subjects [371 children with mean age of 7.8 +/- 3.4 years and 467 adults with mean age of 30.1 +/- 6.6 years]. Group B: 117 controls [70 children with mean age of 6.6 +/- 3 years, and 47 adults with mean age of 30.7 +/- 6 years]. 221 patients with doubtful diagnosis of allergy were excluded [group C]. If we consider the cut-off I of 150 UI [for adults], 75% of allergic subjects have elevated serum total IgE, 62% of adults and 77.6% of children. When doubling the cut-off [cut-off II], 49% of allergic subjects have serum total IgE over 300 UI/ml, 36% of adults and 57% of children. In the control group: 35.8% of patients have total IgE over the cut-off value I and 17% over the cut-off value II. The variation of serum total IgE was related in allergic subjects to the type and the number of symptoms. The levels of total IgE were higher in asthma than in rhinitis and more elevated if the patient has several symptoms. With cut-off I we found a quite good sensibility of the test of 75% [62% in adults and 77.6% in children] and a poor specificity of 64% [68% in adults and 61% in children], with a negative predictive value of 28% and a positive predictive value of 93%. When doubling the cut-off, the sensibility falls to 49% and the specificity was improved at 82%. The serum total IgE measurement was in agreement with prick-tests in 80% of cases and with Phadiatop in 56% of cases if we consider cut-off I. Our results showed a large overlapping of serum total IgE in both allergic and control populations. The measurement of serum total IgE is not helpful for the diagnosis of allergic respiratory diseases because it has a quite good sensibility, a poor specificity and a poor negative predictive value. The test was more sensible and less specific in children


Subject(s)
Humans , Male , Female , Respiratory Hypersensitivity/diagnosis , Respiratory Hypersensitivity/blood , Immunoglobulin E , Asthma , Retrospective Studies , Rhinitis
2.
Tunisie Medicale [La]. 2007; 85 (9): 766-772
in French | IMEMR | ID: emr-134846

ABSTRACT

Lung cancer is frequent and its incidence is increasing in Tunisia and in all over the world. Few published Tunisian studies have described epidemiology of lung cancer. To report the clinical features and outcomes of lung cancer in Tunisia from a retrospective review of 100 consecutive patients seen in F.S.I. hospital in La Marsa. a retrospective study was carried out 100 cases of bronchial carcinoma seen in pulmonology department between 2000 and 2004. We analysed diagnosis modalities. histological subtypes, staging of the disease, treatment strategies and survival. Survival rates were calculated using Kaplan-Meier method. mean age was 59.5 years, sex-ratio at 19. 92%of patients were smokers; the average of tobacco consumption was 48.5 PY. The diagnosis was histologically proven in 90%of the cases. Specimen were obtained by bronchoscop [53.4%of cases], fine-needle lung biopsy [30%], metastasis biopsy [7.7%], surgical biopsy [7.7%] and more rarely by thoracoscopy [1.2%]. Histologically, 39%were squamous carcinomas, 30%adenocarcinomas and 8.7%small cell carcinomas. 51%of non small cell lung carcinomas were stage IV. 26%stage IIIB, 9%stage IIIA and 14%were stage I or II. 6 of 10 patients with small cell carcinomas were with disseminated disease. 18 of 21 patients with resectable tumors receive surge. Patients with locally advanced tumors received combined chemotherapy and radiotherapy. 14 of 46 stage IV patients received palliative chemotherapy. Survival rate was 18%at 2 years


Subject(s)
Humans , Male , Female , Lung Neoplasms/diagnosis , Small Cell Lung Carcinoma , Carcinoma, Non-Small-Cell Lung , Retrospective Studies , Survival Rate
SELECTION OF CITATIONS
SEARCH DETAIL